Brian Baranick - 04 Aug 2022 Form 3 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
Gen. Mgr., Precision Oncology
Signature
/s/ Brian Baranick by Mark R. Busch, attorney-in-fact
Issuer symbol
EXAS
Transactions as of
04 Aug 2022
Net transactions value
$0
Form type
3
Filing time
08 Aug 2022, 16:01:15 UTC
Next filing
23 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EXAS Common Stock 2,868 04 Aug 2022 Direct
holding EXAS Common Stock 159 04 Aug 2022 Held in 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EXAS Restricted Stock Units 04 Aug 2022 Common Stock 8,136 Direct F1, F2
holding EXAS Restricted Stock Units 04 Aug 2022 Common Stock 5,187 Direct F2, F3
holding EXAS Restricted Stock Units 04 Aug 2022 Common Stock 15,817 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit award that vests in three equal annual installments beginning on August 4, 2022.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.
F3 Represents a restricted stock unit award that vests in three equal annual installments beginning on February 19, 2023.
F4 Represents a restricted stock unit award that vests in four equal annual installments beginning on February 25, 2023.